Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, July 16, 2026

Snapshot: Jul 16, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Thu, Jul 16, 2026 Divergent High

Nasdaq tumbled 2.4% and small caps sank 0.6% as high dispersion roiled the tape, with M&A pop-offs (ATAI +33%, CDNA +36%, DSGR +25%) offsetting tech wreckage led by semiconducto…

60% Tech and small-cap selling pressured broad indices as NASDAQ-100 plunged 2.36% and Russell 2000 fell 0.60%, while 50 names cratered at −25% average and VIX spiked 11% signaling renewed fear; S&P 500 slipped just 0.13% due to Financial Services strength offsetting Tech weakness. The regime was divergent chaos: SPY flat, IXIC down hard, yet midcaps and Dow inched up, creating a classic fragmented tape where sector rotation trumped directional clarity.
28% Extreme dispersion (50 gainers averaging +23%, 50 losers averaging −25%) revealed a violent stock-picker's day with leverage inversions and sector concentration amplifying moves; Financial Services dominated both lists (33% of losers, 29% of gainers), while semiconductor names and inverse ETFs surged as their underliers crashed—SOXS +13%, SMCZ +16%, QBTZ +15% all confirming the sector rout.
12% M&A and biotech catalysts drove newsworthy pockets of strength, with ATAI (+33%, Eli Lilly acquisition), CDNA (+36%, Medicare reimbursement win), VEEE (+36%, merger), and DSGR (+25%, take-private) proving the only major narratives in a tape otherwise dominated by fear and technical liquidation.

Financial Services drove 33% of losers 5 names returned after long absences CDNA — first appearance MAN — first appearance

Market Regime

Thu, Jul 16, 2026 Neutral conf: low macro · prototype

Neutral −100 … +100 · + tailwind / − headwind

VIX16.7 Drawdown-1.0% Held8d · established SinceJul 7

Top drivers: S&P drawdown (60d) ▲ S&P vs 20d avg ▲ VIX 5d momentum ▼

processId: history-market-regime

Market Indexes

Thu, Jul 16, 2026 13

S&P 500

7,533.77

−9.87

-0.13%

Dow Jones

52,552.97

+65.56

+0.12%

NASDAQ Composite

25,881.95

−324.94

-1.24%

NASDAQ 100

29,025.77

−701.33

-2.36%

DJ US Total Market

74,616.02

−201.45

-0.27%

Russell 1000

4,102.96

−8.78

-0.21%

S&P MidCap 400

3,796.54

+14.68

+0.39%

Russell 2000

2,974.57

−17.97

-0.60%

Russell 2500

1,264.75

+2.62

+0.21%

Russell 3000

4,285.39

−9.89

-0.23%

Nasdaq Financial-100

7,543.44

+108.35

+1.46%

NIFTY 50

24,072.75

−134.15

-0.55%

VIX

16.73

+1.70

+11.31%

Biggest Gainers

Thu, Jul 16, 2026 50

TGHL

Growhub LtdTechnology

$1.52+$0.71

+86.6%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the cause of the 86.62% gain is not established by available reporting. The jump may reflect a delayed announcement, technical rebound, or undisclosed corporate event.

The absence of recent news makes it impossible to attribute this substantial gain to a specific catalyst. An 86.62% single-day move in a stock trading below $2 could stem from several sources: a delayed earnings announcement or guidance revision not yet indexed by the feed, a corporate action or restructuring, short squeeze activity common in low-priced stocks, technical rebound from oversold conditions, or unconfirmed rumors circulating among retail traders. Without headline corroboration, all are hypotheses. Investors should verify whether Growhub issued any official statements directly through SEC filings or company channels that the news feed may not have captured.

STAK

STAK Inc. Ordinary SharesEnergy

$3.58+$1.45

+68.1%

NASDAQ · Mkt cap $29 M

No news headlines were available in the last 48 hours, so the 68% gain cannot be directly attributed to a disclosed catalyst. The jump likely reflects a technical rebound, short covering, or an undisclosed announcement not yet indexed by Yahoo Finance.

The absence of recent headlines makes it difficult to pinpoint the exact cause of STAK's dramatic 68% intraday gain. STAK Inc. is a small-cap NASDAQ stock, and companies in this category are often more volatile and susceptible to technical factors such as short squeezes, algorithmic buying, or oversold bounces. Without access to the company's recent financial performance, insider activity, or regulatory filings from the snapshot date, I cannot rule out several possibilities: a delayed earnings report or guidance revision, an unannounced corporate action, short-covering activity if the stock had been heavily shorted, or market sentiment shifts driven by sector rotation or broader indices. The lack of news coverage does not rule out a genuine catalyst; it may simply indicate the news has not yet propagated to Yahoo's RSS feed or the move is being driven by intraday trading mechanics rather than fundamental disclosure.

ATPC

Agape ATP CorporationConsumer Defensive

$4.20+$1.68

+66.7%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours, so the 66.67% gain cannot be directly attributed to a disclosed announcement. The jump is likely driven by technical factors, delayed news, or market speculation.

The absence of recent news headlines from Yahoo Finance is notable given the magnitude of the move—a jump of this size would typically be accompanied by a disclosed catalyst such as earnings, clinical trial results, partnership announcements, or strategic guidance. For a microcap biotech or specialty company like Agape ATP, such moves can occur for several reasons: a press release issued outside the monitored news feed window, short covering or squeeze activity, options-related hedging unwinding, insider buying, or unverified market rumors circulating on forums or chat platforms. Without access to the company's own investor relations announcements or SEC filings released within the relevant timeframe, it is impossible to confirm the actual driver. The stock's position as the number three gainer suggests broad market attention, but that attention may not yet be reflected in major news aggregators.

DXST

Decent Holding Inc.Industrials

$2.99+$0.91

+43.8%

NASDAQ · Mkt cap $6.0 M

No news headlines were published in the last 48 hours for DXST, so the 43.75% gain cannot be attributed to a confirmed catalyst. The jump likely reflects technical momentum, delayed news dissemination, or undisclosed corporate developments.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to pinpoint a specific news-driven cause for DXST's 43.75% rally. For a micro-cap or thinly traded stock trading at $2.99, price moves of this magnitude can stem from several sources: a delayed or embargoed earnings announcement or guidance revision not yet syndicated to major feeds, insider trading activity based on unreleased material information, short covering if the stock has high short interest, a technical breakout on low volume, or rumors circulating on less-tracked channels. Without access to the company's own disclosure platform, trading volume context, or short-interest data, assigning a specific cause remains speculative. The rank as 4 biggest gainer suggests this is a real move attracting retail or algorithmic attention, but the motive remains opaque.

IQST

iQSTEL Inc.Communication Services

$1.22+$0.34

+38.4%

NASDAQ · Mkt cap $7.5 M

IQST surged 38.45% on July 16 after announcing preliminary H1 2026 revenue of $207 million, positioning the company toward a $400+ million annual run rate and $8 million EBITDA run rate, signaling strong operational momentum.

The headline released on July 16 at 11:59 UTC reports preliminary first-half 2026 revenue of $207 million, which the company frames as evidence the firm is positioned to exceed a half-billion-dollar annual revenue run rate and surpass an $8 million EBITDA run rate. For a NASDAQ-listed micro-cap trading near $1.22, these projected metrics represent material scale-up narrative that would justify a substantial single-day move, particularly if prior expectations were significantly lower or if the company has struggled historically to achieve profitable growth. The timing of the announcement coinciding with market hours and the stock's ranking as the fifth-biggest gainer suggests the market is responding directly to this guidance update rather than to unrelated technical factors or delayed news absorption.

VEEE

Twin Vee Powercats Co.Consumer Cyclical

$36.18+$9.59

+36.1%

NASDAQ · Mkt cap $6.2 M

Twin Vee PowerCats announced a definitive merger agreement with privately held USFM Corporation, a mineral exploration company focused on critical minerals (nickel, copper, cobalt, PGE) in Greenland, driving a 36% intraday surge.

The headline reveals a transformative M&A event: Twin Vee, a NASDAQ-listed company (likely previously focused on marine products based on its name), is combining with USFM to create a publicly traded entity concentrated on Greenland's mineral assets. This type of strategic combination—particularly one involving critical minerals highly relevant to energy transition and defense supply chains—typically triggers significant investor enthusiasm if perceived as expanding market opportunity or adding strategic assets. The 36% jump reflects strong market approval of either the deal structure, the asset quality, or the strategic pivot itself. Investors appear confident that the critical minerals focus and Greenland's resource potential justify the combination, though the full terms (equity structure, dilution, timeline) are not provided in the headline summary.

CDNA

CareDx, IncHealthcare

$40.34+$10.59

+35.6%

NASDAQ · Mkt cap $2.6 B

CareDx surged 35.6% after Medicare finalized coverage of its transplant molecular testing portfolio through a Local Coverage Determination, removing a key reimbursement uncertainty and validating its core business model.

The headlines establish that CareDx announced Medicare's finalization of a Local Coverage Determination (LCD) for solid organ transplant molecular testing on July 16, 2026. This is a material positive catalyst for a precision diagnostics company dependent on reimbursement coverage. Medicare LCD finalization means the tests are now formally covered by the federal program, which typically drives adoption and revenue visibility. One headline noted the stock initially jumped 20% on the announcement, though the final tally of 35.6% suggests either additional positive interpretation, short-covering, or momentum-driven trading into the close. The second headline about Q2 earnings on July 30 is procedural and likely not a direct driver. For a diagnostic company, reimbursement clarity is foundational to revenue predictability, making this a reasonably proportionate catalyst for a significant single-day move.

ATAI

Atai Beckley Inc.Healthcare

$7.15+$1.79

+33.4%

NASDAQ · Mkt cap $2.7 B

Eli Lilly announced an acquisition of AtaiBeckley for up to $3.8 billion, with an immediate cash payment of $6.75 per share, triggering a 33% surge as investors reacted to the takeover premium and validation of the psychedelics sector.

The move is directly attributable to the M&A announcement. Multiple sources confirm that Eli Lilly agreed to acquire AtaiBeckley on July 16, 2026, with an initial cash consideration of $2.8 billion (at $6.75 per share) plus up to $1 billion in regulatory and commercial milestones. The stock opened around $5.36 and jumped to approximately $7.15, reflecting the takeover premium. The deal also boosted sentiment across the psychedelics sector more broadly, as it represented validation from a major pharmaceutical company entering the space for mental health therapies. The timing of the announcement—released during premarket and early trading hours on July 16—explains why the rally occurred throughout the day.

MAN

ManpowerGroup Inc.Industrials

$51.65+$12.63

+32.4%

NYSE · Mkt cap $2.9 B

ManpowerGroup reported Q2 2026 earnings that beat both top and bottom-line estimates, with revenue up 6-7.5% year-over-year and EPS of $1.13 versus analyst expectations significantly lower, driving the 32% single-day gain.

The equity rally is directly traceable to ManpowerGroup's second-quarter 2026 earnings announcement released on July 16. The company delivered revenue of $4.86 billion (up 7.5% year-over-year), exceeding Wall Street consensus by 3.76%. More notably, net earnings of $1.13 per diluted share crushed estimates by 3.13%, representing a dramatic swing from a net loss of $1.44 per share in the prior year quarter. The earnings call highlighted strong organic growth in the core Manpower staffing business driven by improving demand across multiple markets, plus management's commitment to scale AI-powered productivity tools. The magnitude of the EPS beat and year-over-year profit turnaround appear sufficient to explain a 32% single-session jump. The positive spillover effect on competitor Kforce (up 5.8%) suggests the market is pricing in sector-wide tailwinds as well.

NBRGR

Newbridge Acquisition Limited Rights 2026-21.10.27 For Shares

$0.25+$0.06

+31.5%

NASDAQ

No news headlines were published in the last 48 hours for NBRGR, so the 31.53% spike on July 16 cannot be directly tied to a specific catalyst. The move likely reflects technical or structural dynamics common to thinly-traded rights offerings.

The absence of recent news is striking given the stock's strong single-day performance ranking it tenth among all NASDAQ gainers. NBRGR is a rights offering expiring in October 2027, a financial instrument typically sensitive to small order flow, bid-ask spreads, and time-decay dynamics. Rights offerings trade with low volume and wide spreads, making percentage moves volatile even on modest absolute dollar volume. Without headline evidence, the move could plausibly stem from several categories: a delayed or not-yet-indexed announcement affecting the underlying Newbridge acquisition, coordinated accumulation by a shareholder, expiration-related hedging activity, or purely technical mean reversion. Any of these would be consistent with micro-cap optionality trades, but none can be confirmed from the available information.

LIMN

Liminatus Pharma, Inc. Class A Common StockHealthcare

$0.15+$0.03

+29.0%

NASDAQ · Mkt cap $9.4 M

No news headlines were found in the last 48 hours to explain the 29% gain in LIMN stock, so the catalyst remains unknown without additional context.

Liminatus Pharma stock jumped 29% on July 16, 2026, but no recent news headlines were available to identify a specific catalyst. At $0.15 per share, this is a micro-cap pharmaceutical stock, a category prone to volatile moves on minimal volume triggered by various catalysts. Possible explanations include delayed or unreported news such as clinical trial results, regulatory announcements, partnership deals, insider buying signals, or short covering. Alternatively, the move could reflect technical factors like algorithmic trading on a thinly traded security or broader market sentiment shifts in the biotech sector. Without substantive information about Liminatus Pharma's pipeline, financial position, or recent corporate actions, attributing the move to any specific cause would be speculation.

FSHPR

Flag Ship Acquisition Corporation

$0.10+$0.02

+28.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 28% gain on this penny stock appears driven by technical trading, retail interest, or undisclosed developments not yet captured in major financial media.

Flag Ship Acquisition Corporation is a SPAC, a shell company designed to merge with or acquire an operating business. SPACs and penny stocks in general are highly sensitive to small volumes of trading and retail attention, and can experience sharp price swings on minimal news or even pure momentum. The absence of any news headlines in the last 48 hours despite a 28% single-day jump suggests this move was either driven by technical factors such as short covering or bullish chart signals, by social media or retail trading enthusiasm, by a delayed or local announcement not yet indexed by Yahoo Finance RSS, or by internal company developments not yet publicized. Without specific news or structural insight into current SPAC activity tied to this entity, the exact catalyst remains unclear.

MAAS

Maase Inc.Financial Services

$20.95+$4.38

+26.4%

NASDAQ · Mkt cap $7.0 B

No news headlines were found in the last 48 hours, so the 26.43% surge cannot be attributed to a specific announced event. The move likely stems from technical buying, delayed news digestion, or unverified market rumors.

The absence of any recent news headlines is notable given MAAS's substantial single-day gain of 26.43%, placing it in the top 13 biggest gainers on NASDAQ. Without confirmed catalysts in the provided information, the rally could reflect several common drivers: a delayed market reaction to an announcement from more than 48 hours prior that the RSS feed did not capture, technical momentum or short covering if the stock had been oversold, or unconfirmed speculation circulating on social media or trading forums. Without access to company fundamentals, sector catalysts, or insider positioning data, attributing this move to a specific catalyst would be speculation. The timing and magnitude suggest something more than random noise, but the evidence does not establish what that something is.

DSGR

Distribution Solutions Group, Inc.Industrials

$34.43+$6.95

+25.3%

NASDAQ · Mkt cap $1.6 B

Distribution Solutions Group agreed to be taken private by LKCM Headwater Investments affiliates for $35.00 per share in an all-cash transaction announced on July 16, directly explaining the 25% stock surge.

The headlines establish that DSGR entered into a definitive merger agreement on July 16, 2026, with entities controlled by LKCM Headwater Investments to acquire the company at $35.00 per share in cash. The stock closed at $34.43, which is slightly below the deal price, a typical pattern for announced acquisitions trading at a small discount to account for deal risk and time-value-of-money effects. The 25% single-day jump aligns precisely with the gap between the previous closing price (approximately $27.45, calculated from the $34.43 price and 25% gain) and the $35.00 announced deal price. This is a textbook M&A catalyst with no ambiguity about causation. The ancillary news about TestEquity expanding environmental chamber sales is unrelated to the merger and did not drive the move.

RKLZ

DEFIANCE DAILY TARGET 2X SHORT RKLB ETF

$5.11+$0.97

+23.4%

NASDAQ

No headlines were found in the last 48 hours, but RKLZ is a 2x inverse leveraged ETF tracking Rocket Lab, so a sharp 23% gain likely reflects a significant decline in the underlying RKLB stock price.

RKLZ is the Defiance Daily Target 2X Short RKLB ETF, meaning it moves in the opposite direction of Rocket Lab's stock with 2x daily leverage. A 23% gain in RKLZ corresponds to roughly an 11-12% decline in RKLB on an unlevered basis, or potentially more given compounding effects in leveraged daily rebalancing. Without news headlines about Rocket Lab itself, the most probable causes for such a sharp move would be either significant negative company-specific news about Rocket Lab (a failed launch, guidance cut, leadership change, or funding issues) or broad sector selloff in aerospace/defense stocks. Since no headlines are provided, the cause cannot be definitively identified from available information.

KXIN

Kaixin Auto HoldingsConsumer Cyclical

$5.79+$1.07

+22.7%

NASDAQ · Mkt cap $8.8 M

No news headlines were found in the last 48 hours, so the 22.67% jump in KXIN cannot be attributed to a specific disclosed event. The move likely reflects technical trading, short-covering, or undisclosed developments.

No recent news was available to explain KXIN's significant intraday gain of 22.67%. This leaves several plausible but unconfirmed categories: (1) short-squeeze activity, particularly common in lower-priced stocks with high short interest, (2) technical breakout or oversold bounce from prior weakness, (3) rumors or social media catalysts not yet reflected in official headlines, or (4) corporate developments announced through channels not yet indexed by Yahoo Finance RSS. Kaixin Auto operates in the competitive Chinese automotive sector, where regulatory changes or production announcements can move shares sharply. Without corroborating news, however, it is impossible to pinpoint a specific cause.

LGPS

LogProstyle Inc.Industrials

$1.37+$0.25

+22.3%

APLM

Apollomics, Inc.Healthcare

$23.27+$4.08

+21.3%

NASDAQ · Mkt cap $52 M

No news headlines were available in the last 48 hours to explain the 21.26% gain in APLM stock, so the catalyst remains unknown from public sources. The jump likely stems from clinical trial results, a partnership announcement, or other corporate development not yet reflected in the provided news…

Apollomics is a clinical-stage biopharmaceutical company focused on oncology therapeutics, and companies in this sector commonly experience sharp single-day moves on catalysts such as positive Phase 2 or Phase 3 trial data, FDA breakthrough designation grants, strategic partnerships, financing announcements, or regulatory decisions. The absence of headlines in the Yahoo Finance RSS feed over the last 48 hours does not rule out that such a catalyst occurred—it may indicate a delay in news aggregation, a non-traditional announcement channel, or an intraday development that has not yet been broadly indexed. Alternatively, the move could reflect delayed market reaction to news from slightly earlier, technical factors, or a rumor not yet confirmed by official channels. Without specific news grounding this move, we can only infer it falls within the typical set of drivers for clinical biotech stocks.

EDHL

Everbright Digital Holding Limited Ordinary SharesCommunication Services

$4.27+$0.74

+21.0%

NASDAQ · Mkt cap $6.5 M

No news headlines were found in the last 48 hours, so the 20.96% gain on July 16 cannot be directly attributed to a specific announced catalyst. The move likely reflects technical or market-specific factors.

The absence of any news in the provided headlines makes it impossible to identify a concrete catalyst for EDHL's 20.96% single-day gain. This is a notable gap when a stock ranks in the top 20 gainers. Possible explanations within the inference category include technical factors such as short covering or momentum buying, delayed market reaction to an earlier announcement not captured in the 48-hour window, a sector rotation into digital or technology names, or word-of-mouth developments not yet reflected in major financial news feeds. Without access to intraday trading activity, options data, or alternative news sources, attributing the move to any specific event would be speculative. The stock's NASDAQ listing and the size of the gain suggest it has adequate liquidity, but without corroborating news, the underlying driver remains unclear.

SVRE

SaverOne 2014 LtdTechnology

$3.14+$0.54

+20.8%

NASDAQ · Mkt cap $4.8 M

No news headlines were found in the last 48 hours, so the 20.77% gain in SVRE shares cannot be directly attributed to a reported corporate event or market announcement. The jump likely reflects technical trading, retail interest, or an undisclosed catalyst.

SaverOne 2014 Ltd is a small-cap Israeli company focused on in-vehicle safety technology, and NASDAQ-listed micro-cap stocks in this category are often thinly traded and prone to sharp moves on modest volume. Without recent news in the provided sources, the rally could stem from several typical catalysts: a positive development in product adoption or partnerships not yet picked up by major news wires, short-covering or technical breakout buying in a stock that may have support from retail or momentum traders, delayed reaction to an earlier announcement, or market-wide sector rotation into IoT or transportation safety. The absence of headlines does not rule out company-specific good news; it simply means it is not reflected in the headline feed provided.

TOP

TOP Financial Group LimitedFinancial Services

$2.52+$0.42

+20.0%

NASDAQ · Mkt cap $1.4 B

No news headlines appeared in the last 48 hours, so the 20% gain likely stems from a technical bounce, short squeeze, or delayed market reaction to an earlier announcement not captured in this snapshot.

TOP Financial Group Limited jumped 20% to $2.52 on July 16, 2026, but no recent headlines are available to explain the move. This absence of reported catalyst is notable. For a microcap financial stock trading at this price level, moves of this magnitude typically reflect one of several dynamics: a short squeeze if the stock has high short interest, a technical reversal after oversold conditions, a delayed market reaction to news released before the 48-hour window, insider activity or rumors not yet reflected in formal news, or sector-wide rallies in fintech or consumer finance. Without access to volume data, short interest, or broader market context for the date, it is difficult to determine which factor drove the move. The lack of earnings, guidance, M&A, or regulatory announcements in the provided headlines leaves this a data-constrained inference.

ARCLR

ARC Group Acquisition I Corp Right

$0.24+$0.04

+20.0%

NASDAQ

No news headlines were found in the last 48 hours, so the 20% gain appears driven by technical trading, SPAC dynamics, or undisclosed developments not captured in the headline feed.

ARCLR is a SPAC rights unit, a security type typically characterized by low liquidity and small trading volumes, making it prone to outsized percentage moves on modest absolute dollar flows. The absence of any news headlines in the past two days means the gain cannot be attributed to company-specific announcements, earnings, regulatory approval, or M&A activity. In SPAC rights, moves of this magnitude often reflect either technical support levels being broken, options positioning, arbitrage activity related to the underlying blank-check company's warrant or share performance, or simply thin-volume trading where a small buyer interest produces a large percentage gain. Without access to intraday volume, short interest, or options data, determining the precise catalyst remains speculative. The most likely drivers in SPAC instruments are internal redemption or merger timing signals, unusual options activity, or passive rebalancing in small-cap indices, but these are inferences rather than established facts.

LBGJ

Li Bang International Corporation Inc. Ordinary SharesIndustrials

$2.19+$0.36

+19.7%

NASDAQ · Mkt cap $58 K

No news headlines were found in the last 48 hours, so the 19.67% gain likely reflects technical trading, market rumors, or delayed news not yet captured in the RSS feed.

Li Bang International Corporation (LBGJ) jumped nearly 20% on 2026-07-16 with no corresponding headlines in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect suggests several non-exclusive possibilities. First, the move may be driven by technical factors—short covering, algorithmic rebalancing, or momentum in a low-volume NASDAQ-listed stock where modest absolute volume can produce large percentage swings. Second, an announcement may have occurred but not yet propagated to the news feed, or may have been released after market close on the prior day. Third, social media chatter or a delayed analyst note could be driving retail interest. Without access to real-time order flow, corporate filings, or intraday news, we cannot pinpoint the catalyst. Investors should check the company's official press releases and SEC Edgar filings directly for confirmation.

SLAI

SOLAI LimitedTechnology

$3.72+$0.57

+18.1%

NYSE · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the cause of SLAI's 18.10% jump cannot be determined from available reporting. The move likely reflects technical trading, delayed news dissemination, or unconfirmed market rumors.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours makes it difficult to pinpoint a specific catalyst for this significant single-day gain. SLAI is ranked 24th among daily gainers, indicating this is a notable move that investors found material enough to push the stock up substantially. Without disclosed earnings, guidance changes, partnership announcements, or other corporate actions to reference, the jump could reflect several non-news-based mechanisms: technical momentum or short covering in a lower-priced stock, delayed dissemination of older news not yet indexed in feeds, options-related hedging adjustments, or unverified social media or private information spreading through retail trading channels. For a micro-cap stock like SLAI trading at $3.72, intraday volume and sentiment shifts can generate outsized percentage moves even in the absence of formal news flow.

GRAN

Grande Group Limited Class A Ordinary SharesFinancial Services

$1.70+$0.26

+18.1%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 18% gain appears to be driven by factors outside the provided information, potentially including technical buying, short covering, or delayed reporting of news events.

The absence of any Yahoo Finance headlines in the last 48 hours for GRAN makes it difficult to pinpoint a specific catalyst for the 18.06% single-day jump. Given that GRAN trades at a low price point of $1.70 and ranks as the 25th biggest gainer, this could reflect technical momentum in a thinly traded microcap stock, potential short squeeze activity if the stock carries significant short interest, or a delayed market reaction to news that has not yet been picked up by major financial feeds. Microcap and penny-range stocks are particularly susceptible to rapid moves on modest volume, insider activity, or social media attention that may not immediately surface in mainstream news aggregators. Without additional context, the specific corporate event or market dynamic remains unclear.

VSA

VisionSys AI Inc.Consumer Defensive

$3.82+$0.58

+17.9%

NASDAQ · Mkt cap $9.5 M

No news headlines were found in the past 48 hours for VisionSys AI Inc., so the 17.90% gain cannot be attributed to a reported announcement or event. The move likely reflects technical trading, delayed news dissemination, or market sentiment unrelated to public disclosures.

The absence of any recent news headlines is notable given the stock's substantial single-day gain of 17.90%, ranking it among the top 26 gainers on NASDAQ. For a micro-cap or small-cap AI company, moves of this magnitude can occur for several reasons unrelated to immediate news coverage. One hypothesis is that the stock experienced technical buying pressure, possibly from short covering or algorithmic rebalancing in a thinly traded security. Another plausible explanation is that news was released through a channel not captured by Yahoo Finance RSS (such as a direct press release, SEC filing, or earnings surprise) but has not yet propagated to major news aggregators at the time of snapshot. VisionSys AI is positioned in the AI sector, which remains subject to sentiment-driven rallies and sector rotation flows. Without access to the company's latest filings, earnings calendar, or insider trading activity, attribution remains speculative.

MERC

Mercer International Inc.Basic Materials

$0.67+$0.10

+17.3%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 17.34% gain in MERC stock cannot be tied to a specific announced event; the move likely reflects technical trading, sector momentum, or untracked catalysts.

The absence of recent news headlines for a stock that jumped 17.34% in a single day is notable and limits our ability to pinpoint a cause. Mercer International is a global paper and pulp manufacturer, a cyclical commodity-linked business. Moves in this sector can be driven by shifts in pulp or timber prices, currency fluctuations affecting export competitiveness, short-covering in a thinly traded stock, or delayed reporting of company announcements not yet indexed by news aggregators. At a price of $0.67 the stock may also be subject to retail trading interest or technical chart breakouts. Without headline confirmation, we cannot rule out technical rebound, sector rotation into commodity stocks, or unconfirmed corporate developments.

CLIK

Click Holdings LimitedConsumer Cyclical

$1.73+$0.25

+16.9%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 16.89% gain likely stems from technical trading, delayed news, insider activity, or sector momentum rather than any identifiable corporate announcement.

Click Holdings Limited jumped 16.89% to $1.73 on July 16, 2026, but no recent news headlines are available to explain the move directly. The stock's low price point and mid-cap ranking among daily gainers suggest it may be sensitive to technical factors, short covering, or retail interest. Without access to company earnings, guidance, product announcements, regulatory approvals, or M&A news, the catalyst remains obscure. Possible explanations include delayed market reaction to prior news, changes in analyst ratings, sector rotation into the stock's industry, or speculative trading in a lower-priced security. Without substantive information about Click Holdings' business model or capital structure, attributing the move to a specific mechanism is not possible.

MDCX

Medicus Pharma Ltd. Common StockHealthcare

$0.41+$0.06

+16.5%

NASDAQ · Mkt cap $17 M

Medicus Pharma announced FDA feedback and IRB approval for an optimized Phase 2 study of Teverelix for acute urinary retention, which reduces the patient enrollment target and advances the clinical program, driving a 16.53% single-day gain.

The company received two positive regulatory milestones on the same day: FDA feedback and central IRB approval for a Phase 2 study redesign. The key commercial advantage highlighted is capital efficiency—the optimized study will enroll approximately 126 patients versus 390 under the previous plan, meaningfully reducing development costs and timeline risk while still advancing a potentially valuable asset in urology. For a small-cap biotech trading at $0.41, clinical advancement combined with reduced capital requirements is a meaningful positive catalyst, as it both validates the development path and extends cash runway. The timing and specificity of the announcement, combined with the stock's rank as the 29th largest daily gainer, suggests this was the primary driver of the move.

CJMB

Callan JMB Inc. Industrials

$0.86+$0.12

+16.5%

NASDAQ · Mkt cap $15 M

Callan JMB announced a strategic partnership with Alabama State University involving a potential $414 million five-year pharmaceutical manufacturing revenue opportunity, likely driving the 16.51% gain on the day of the announcement.

The news headline establishes a concrete partnership deal between Callan JMB and Alabama State University focused on advancing U.S. pharmaceutical manufacturing and supply chain resilience. Management explicitly cited a potential $414 million five-year revenue opportunity associated with this initiative. For a microcap stock trading near $0.86, this scale of potential contract value represents material upside to growth expectations and validates the company's positioning in the critical pharmaceutical manufacturing sector. The announcement appears directly tied to the timing of the stock's surge into the top 30 gainers, suggesting investors responded positively to both the partnership validation and the specific revenue guidance provided by management. No contradictory information is present in the available headlines.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$1.98+$0.27

+15.8%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 15.79% gain cannot be attributed to any identifiable catalyst disclosed in available sources. The move is likely driven by technical trading, short covering, or undisclosed company developments.

The absence of recent news headlines creates a challenge in explaining this substantial single-day gain for EHGO. The stock is ranked 31st among daily gainers, indicating broad market attention, yet no earnings announcements, regulatory approvals, partnership deals, or guidance changes appear in the available news feeds. For micro-cap or thinly traded securities like this, price spikes absent headline catalysts are often driven by technical factors such as short squeezes, options expiration effects, or momentum trading following a prior downtrend. Alternatively, the catalyst may exist but simply not have been captured in the Yahoo Finance RSS feed within the 48-hour window, or the company may have issued a press release that has not yet propagated widely. Without additional information about EHGO's market cap, trading volume, or short interest levels, pinpointing the mechanism remains speculative.

SMCZ

Daily Target 2X Short SMCI ETF

$11.97+$1.63

+15.8%

NASDAQ

No news headlines were published in the last 48 hours, but SMCZ is a 2X leveraged short ETF on Super Micro Computer (SMCI), so a 15.76% gain likely reflects a significant drop in SMCI's stock price that day.

SMCZ is designed to deliver twice the daily inverse return of the SMCI stock price. Without any news headlines provided for the past 48 hours, we cannot identify a specific catalyst for today's move. However, the structure of this security explains the mechanism: if SMCI fell sharply today, SMCZ would automatically gain roughly double that percentage. The most likely causes of an SMCI sell-off would be either negative company-specific news (earnings disappointment, guidance cut, executive changes, competitive pressure) or sector-wide weakness in semiconductor stocks. A secondary possibility is technical/momentum trading if SMCI had become oversold and triggered institutional selling or short-covering patterns. Without access to SMCI's price action or relevant headlines, we cannot determine which hypothesis is correct.

OSRH

OSR Holdings, Inc.Healthcare

$0.49+$0.07

+15.5%

NASDAQ · Mkt cap $21 M

No news was found in the last 48 hours, so the 15.51% gain likely reflects technical trading, a delayed news announcement, or speculative positioning in this micro-cap stock.

OSR Holdings traded up sharply with no corresponding headlines in the recent news cycle. For a stock trading at $0.49 with this level of daily volatility, the move could stem from several sources: a formal news release that has not yet propagated to Yahoo Finance, short covering or technical breakout trading common in penny stocks, or retail sentiment shifts on social media or message boards. Without earnings reports, regulatory approvals, or M&A announcements visible in the provided sources, we cannot pinpoint a specific catalyst. Micro-cap stocks in this price range often experience outsized moves on relatively light volume or delayed information dissemination, making it difficult to establish causation with only price action and absence of news as evidence.

BTTC

Black Titan CorporationFinancial Services

$0.91+$0.12

+15.5%

ALISR

Calisa Acquisition Corp Right

$0.70+$0.09

+15.2%

NASDAQ

A GoodVision AI announcement about a 100 MW AI factory partnership in Japan was published today, but there is no explicit connection stated in the headline to Calisa Acquisition Corp Right, making the link to this stock's 15% gain unclear without additional context.

The news headline describes GoodVision AI establishing an AI factory partnership in Japan, which is a positive development for that company. However, ALISR is a SPAC right (a warrant-like security tied to a blank-check acquisition vehicle), and the headline provides no indication that GoodVision is the target of Calisa's acquisition or that any deal has been announced. Without confirmation that GoodVision AI is merging with or being acquired by Calisa Acquisition Corp, the causal link between this news and ALISR's rise remains speculative. The gain could reflect SPAC arbitrage positioning, retail speculation following AI-sector enthusiasm, or an unrelated technical bounce. Rights are particularly volatile and sensitive to merger-event probabilities, so if investors believe Calisa is about to announce a deal with GoodVision, that expectation alone could drive the move.

RGTZ

Daily Target 2X Short RGTZ ETF

$6.27+$0.82

+15.0%

NASDAQ

No news headlines were found in the last 48 hours. RGTZ is a 2X inverse leveraged ETF, so the +15% gain most likely reflects a sharp decline in its underlying stock or index on July 16th.

RGTZ is a Daily Target 2X Short ETF, meaning it is structured to deliver twice the inverse daily return of its underlying benchmark. When the underlying asset falls sharply, this ETF rises proportionally. With no news available about RGTZ itself or its issuer, the +15% jump is almost certainly attributable to a significant one-day drop in the underlying security or index that RGTZ tracks. Leveraged inverse ETFs are designed to amplify downside moves in their reference benchmark, so a 7-8% decline in the underlying would produce roughly this magnitude of gain. Without knowing which security RGTZ references, we cannot identify the specific catalyst, but the move is mechanically consistent with a strong negative trading day in the underlying asset.

NWTG

Newton Golf CompanyConsumer Cyclical

$1.15+$0.15

+15.0%

NASDAQ · Mkt cap $6.3 M

No news headlines were found in the past 48 hours to explain Newton Golf's 15% gain, so the cause remains unclear without additional context or delayed reporting.

Newton Golf Company jumped 15% on July 16, 2026, but zero news headlines appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect between price action and published information creates genuine uncertainty. Small-cap stocks like NWTG, trading near $1.15, are often susceptible to technical catalysts such as short covering, options expiration mechanics, or large single-position trades that can move the stock sharply without fundamental news. Alternatively, the catalyst could be a delayed or localized announcement not yet picked up by major financial news services, an earnings surprise, or insider activity. Without access to real-time trading data, SEC filings, or company press releases beyond the Yahoo feed, identifying the specific driver is not possible. The golf equipment industry does face periodic sector rotation and equipment launch cycles that can drive smaller competitors, but that remains speculative without supporting headlines.

QBTZ

Defiance Daily Target 2X Short QBTS ETF

$6.66+$0.86

+14.8%

NASDAQ

No news headlines were published about QBTZ in the last 48 hours, but the 14.83% gain is likely driven by a sharp decline in the underlying QBTS (Nasdaq-100) index, since QBTZ is a 2X inverse leveraged ETF that amplifies downward moves.

QBTZ is a daily rebalancing leveraged inverse ETF designed to deliver negative 2X the daily return of the Nasdaq-100. When the underlying Nasdaq-100 declines significantly, QBTZ rises proportionally. No news headlines were found in the Yahoo Finance RSS feed for the past 48 hours, so there is no specific event tied to QBTZ itself. The most likely explanation is structural: the Nasdaq-100 experienced a material one-day selloff on July 16, 2026, which would automatically trigger a corresponding 2X amplified gain in this inverse product. Without access to intraday Nasdaq-100 price data for that date, we cannot confirm the magnitude of that selloff, but the gain magnitude is consistent with a roughly 7 percent decline in the underlying index.

SFWL

Shengfeng Development LimitedIndustrials

$0.78+$0.09

+13.8%

NASDAQ · Mkt cap $73 M

No news headlines were available in the last 48 hours, so the 13.77% gain likely reflects either technical trading, delayed market reaction to an older announcement, or micro-cap volatility typical of penny stocks trading at $0.78.

The absence of any recent news in the Yahoo Finance RSS feed for SFWL makes it difficult to pinpoint a specific catalyst. Shengfeng Development is a micro-cap stock trading below one dollar, which typically experiences higher volatility and can move sharply on low volume, retail interest, or delayed dissemination of company announcements not yet reflected in major news feeds. Possible explanations include technical oversold bounces, short covering, retail or algorithmic trading activity, a press release issued directly by the company but not yet picked up by aggregators, or market reaction to news from a previous day that took time to propagate. Without access to company filings, insider activity data, or direct press releases, the specific reason remains unclear.

OPRT

Oportun Financial CorporationFinancial Services

$6.45+$0.78

+13.8%

NASDAQ · Mkt cap $350 M

OPRT jumped 13.76% on a single analyst note highlighting the stock as attractively priced with strong momentum, suggesting renewed investor interest in the financial services name despite lack of new company-specific catalysts.

The only headline provided is a Yahoo Finance analyst opinion piece from July 15 suggesting OPRT is a good value play with strong momentum characteristics. This is not company news—no earnings beat, guidance change, partnership announcement, or material business update. The analyst commentary itself appears to be the market catalyst, likely triggering algorithmic buying and retail interest in a stock that had already shown positive momentum. Oportun is a fintech lender, so moves can be driven by sentiment shifts around consumer credit demand, regulatory outlook, or relative valuation in the sector. However, the headline does not establish any of these as the actual cause; it merely frames the stock as attractive at current levels. Without access to intraday volume data or confirmation of what triggered the initial move, the jump appears primarily sentiment-driven rather than news-driven.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$52.02+$6.04

+13.1%

AMEX

SOXS surged 13.14% following a sharp decline in semiconductor stocks driven by fears that a Chinese memory chip competitor raised substantially more capital than expected, intensifying competition concerns in the sector. The 3X leveraged bear ETF gains when its underlying index falls.

The headlines establish a clear catalyst: a Chinese memory chip company announced a fundraising round roughly double Wall Street expectations, triggering weakness across the semiconductor sector. This is precisely the type of event that drives a 3X daily inverse semiconductor ETF higher. SOXS is designed to profit from declines in semiconductor stocks, so when the Semiconductor Index fell sharply on competitive pressure fears, SOXS amplified that downward move through its 3X leverage. The secondary headline about profiting from an AI trade collapse provides context for investor sentiment—suggesting some market participants are positioning for a potential correction in the AI-driven rally that has benefited semiconductor stocks. The mechanism is straightforward: weaker underlying semiconductors equal stronger SOXS performance.

VRAX

Virax Biolabs Group LimitedHealthcare

$3.90+$0.45

+13.0%

NASDAQ · Mkt cap $2.5 M

Virax Biolabs announced a shareholder update following its fiscal 2026 annual report and a new commercial supply agreement with Fosun Diagnostics, likely driving the 13% gain as investors responded positively to both the financial results and the strategic partnership.

The headline indicates that CEO James Foster released a shareholder update tied to two material events: the publication of the fiscal 2026 annual report and execution of a commercial supply agreement with Fosun Diagnostics. While the headline does not provide specific financial metrics, earnings data, or contract terms, the announcement of a new commercial supply partnership is typically viewed as a positive catalyst for biotech companies focused on diagnostics, as it represents revenue validation and market expansion. The fact that this update was published on the same day as the stock's 13% jump, combined with Virax's focus on immune response detection and in vitro diagnostics, suggests investors perceived the annual results and the Fosun deal as good news. However, the specific financial details and agreement terms remain unclear from the headline alone.

ALBT

Avalon GloboCare Corp.Real Estate

$0.31+$0.04

+12.9%

NASDAQ · Mkt cap $2.9 M

Avalon GloboCare announced expansion of its AI product portfolio with a planned late Q3 2026 launch of Beacon, a subscription-based software platform, which likely drove the 12.94% gain as the market reacted positively to new recurring SaaS revenue growth prospects.

The company disclosed plans to launch Beacon, described as an agentic generative engine optimization platform targeting small businesses. This represents a concrete expansion of Avalon's SaaS portfolio, adding to its existing Catch-Up platform. The announcement specifically highlights a subscription-based model, which appeals to investors seeking recurring revenue visibility. The timing—late Q3 2026—is close enough to suggest near-term execution. For a micro-cap stock trading at $0.31, any tangible product expansion with SaaS characteristics can trigger momentum buying, particularly if investors perceive it as addressing market demand for AI-powered business tools. The relatively broad portfolio expansion narrative combined with the subscription revenue angle likely resonated with growth-focused traders in a sector where AI applications remain compelling despite broader valuation pressures.

IONZ

Defiance Daily Target 2x Short IONQ ETF

$5.44+$0.62

+12.9%

NASDAQ

No news headlines were found in the last 48 hours, but IONZ is a 2x inverse leveraged ETF on IONQ, so a sharp 12.86% gain likely reflects a significant decline in the underlying IonQ stock price over the snapshot period.

IONZ is a daily target 2x short leveraged ETF tracking IonQ, meaning it moves in the opposite direction and with approximately double the magnitude of IonQ's price movements. Without news directly reported for IONZ, the most likely explanation is that IonQ (IONQ) itself experienced a substantial intraday or recent decline of roughly 6-7% or more, which would amplify into a gain for this inverse product. The absence of headlines in the financial feed does not rule out a real market move in the underlying security; delays in news aggregation, pre-market announcements, or earnings-related volatility in IonQ are plausible candidates. Alternatively, a technical or volatility event affecting quantum computing equities broadly, or a leveraged rebalancing within the ETF itself, could have contributed.

RHI

Robert Half Inc.Industrials

$41.33+$4.63

+12.6%

NYSE · Mkt cap $4.4 B

Robert Half rose 12.62% likely driven by positive analyst commentary on its high ROE and liquidity position combined with upcoming earnings results scheduled for July 23, generating pre-earnings momentum and investor optimism.

The two headlines available do not directly announce earnings beats, guidance changes, or major corporate actions. However, the July 15 article explicitly highlights Robert Half's strong financial fundamentals including high return on equity, robust liquidity, and shareholder return programs, which are typically bullish factors that attract institutional investors. The follow-up announcement on July 16 that earnings will be released July 23 at 4:05 p.m. ET creates a concrete near-term catalyst and may have triggered pre-earnings buying momentum. The confluence of positive fundamentals commentary and the imminent earnings date likely encouraged investors to build positions ahead of results. The stock's ranking as the 45th biggest gainer suggests broad market interest rather than a niche catalyst, consistent with a positive sentiment shift rather than a company-specific event.

LVWR

LiveWire Group, Inc.Consumer Cyclical

$0.73+$0.08

+12.6%

NYSE · Mkt cap $254 M

No news headlines were published in the last 48 hours, so the 12.59% gain cannot be attributed to disclosed company announcements or major events. The move likely reflects technical trading, investor sentiment shifts, or undisclosed market-moving information.

LiveWire Group is an electric motorcycle manufacturer that has historically been a volatile, lower-priced equity often subject to retail trading activity and momentum-based moves. The absence of news in the Yahoo Finance RSS feed over the past two days means the jump cannot be tied to earnings results, product announcements, partnership deals, regulatory actions, or guidance changes. In such cases, moves in stocks like LVWR are frequently driven by technical factors such as short covering, chart-based support level breaks, options expiration activity, or broader sector sentiment shifts in the EV space. Without contemporaneous news, attributing the move to any specific corporate event would be speculation. Insider trading activity or delayed earnings releases from earlier in the week remain possibilities worth checking, but these cannot be confirmed from the evidence at hand.

GDC

GD Culture Group LimitedCommunication Services

$1.70+$0.19

+12.6%

NASDAQ · Mkt cap $7.8 M

No news headlines were found in the last 48 hours, so the +12.58% gain on GDC cannot be directly attributed to a specific announced event. The move may reflect technical trading, delayed news dissemination, or market sentiment shifts.

GDC experienced a notable intraday rally to rank 47 among daily gainers despite zero news coverage appearing in the Yahoo Finance feed over the relevant period. This disconnect between significant price action and absent headlines suggests either a delayed news cycle, an announcement not yet picked up by major feeds, or a technical/sentiment-driven move. For smaller-cap stocks like GDC Culture Group, catalysts that typically drive double-digit daily moves include earnings surprises, guidance changes, analyst upgrades, strategic partnerships, or short-covering activity. Without headline confirmation, we cannot identify which category applies here. It is also possible that news broke after the snapshot timestamp or through channels not captured by the Reuters feed shown.

AERT

Aeries Technology, IncIndustrials

$7.07+$0.78

+12.4%

NASDAQ · Mkt cap $40 M

Aeries Technology surged 12.4% after announcing regained compliance with Nasdaq's minimum bid price requirement on July 16, lifting it out of delisting risk and restoring investor confidence in the stock's continued exchange listing.

The July 16 headline announcing regained Nasdaq compliance is the most probable catalyst for the 12.4% gain. Stocks trading below Nasdaq's $1.00 minimum bid price face delisting risk, which creates significant uncertainty and often depresses valuations. By regaining compliance, AERT has eliminated an existential threat to its public listing status. This removes a major overhang that likely weighed on the stock and signals operational stabilization or a successful pricing recovery. The other headlines from July 14-15 mention Aeries only generically in analyst blogs covering multiple stocks and offer no company-specific news that would explain today's move. The timing and specificity of the compliance announcement align directly with the stock's strong intraday performance.

ENTX

Entera Bio Ltd.Healthcare

$2.00+$0.22

+12.4%

NASDAQ · Mkt cap $153 M

No news headlines were found in the last 48 hours to explain ENTX's 12.36% gain on July 16, 2026. The driver of this biotech stock's move remains unclear from available information.

Entera Bio is a clinical-stage biopharmaceutical company focused on oral delivery of biologics, so price movement typically correlates with clinical trial results, regulatory milestones (FDA feedback letters, approval decisions), partnership announcements, or financing events. The absence of any recent headlines in the Yahoo Finance feed suggests the catalyst either occurred outside major news channels, was delayed in reaching public sources, or the move may have been driven by technical factors such as short covering, options expiration effects, or sector-wide momentum in biotech. Without access to company press releases, investor relations updates, or real-time trading volume data, attribution remains speculative.

PHIO

Phio Pharmaceuticals Corp.Healthcare

$1.00+$0.11

+12.3%

NASDAQ · Mkt cap $12 M

Phio Pharmaceuticals announced favorable patent decisions across the US, Canada, and Japan for its INTASYL gene silencing platform on July 15, strengthening intellectual property protection around its lead technology, likely driving the 12.34% gain.

The company released two nearly identical announcements on July 15 regarding multiple patent allowances and grant decisions for INTASYL compounds across three major jurisdictions. Patent portfolio expansions for biotech firms can be meaningful catalysts because they extend competitive moats, improve licensing potential, and reduce risk of generic competition or legal challenges. For a clinical-stage platform company like Phio, securing international patent protection—particularly in the US, Canada, and Japan—signals progress in de-risking its core intellectual property and may improve its perceived long-term value. The timing of the announcement (July 15 afternoon) aligns with the trading day in which the stock moved up 12.34% to rank as the 50th largest gainer on NASDAQ.

Biggest Losers

Thu, Jul 16, 2026 50

NVVE

Nuvve Holding Corp.Consumer Cyclical

$8.38−$13.18

-61.1%

NASDAQ · Mkt cap $729 K

No news headlines were found in the last 48 hours, so the 61% single-day collapse in NVVE cannot be directly attributed to a reported event. The drop likely reflects an undisclosed corporate announcement, earnings miss, regulatory development, or severe technical/liquidity event.

Nuvve Holding Corp is a vehicle-to-grid (V2G) and charging infrastructure company, typically a cyclical and sentiment-driven equity. A 61% single-day loss without accompanying news in the RSS feed is striking and suggests either a delay in news propagation, a pre-market or after-hours announcement not yet indexed, or an event that triggered before the snapshot time. Common catalysts for this magnitude of move in small-cap energy-transition stocks include disappointing quarterly earnings, loss of a major contract or partnership, failed capital raise, executive departure, covenant breach, or short seller report. Without news confirmation, the actual trigger remains unknown, though the scale of the move indicates something material rather than technical.

SOBR

SOBR Safe, Inc.Technology

$1.00−$1.07

-51.7%

NASDAQ · Mkt cap $1.6 M

SOBR announced warrant exercises generating $3.1 million in proceeds to shore up its balance sheet ahead of a proposed merger and regain Nasdaq compliance, but the 51.69% single-day collapse suggests market skepticism about the dilution, merger prospects, or underlying business viability.

The headline reports a positive corporate action: warrant exercises that bring cash in and support both a merger and Nasdaq listing compliance efforts. On the surface this is constructive. However, a 51.69% single-day drop on such an announcement is unusual and points to either severe negative market sentiment about the merger itself, concern that the $3.1 million proceeds are insufficient given the company's cash needs, or that the dilution embedded in warrant exercises is being repriced harshly by the market. It is also possible that investors already knew a warrant exercise was coming and today's move reflects a different catalyst entirely—bad merger news, insider selling, or technical breakdown—that was not captured in the headline provided. Without access to the full press release details, the merger counterparty, or intraday volume patterns, we cannot definitively rule out non-news-based triggers.

PLAG

Planet Green Holdings Corp.Industrials

$0.95−$0.88

-48.2%

AMEX · Mkt cap $12 M

Planet Green Holdings announced a strategic digital marketing agreement with AI company iFLYTEK on 2026-07-16, but the -48.20% crash suggests market skepticism about the deal's value or timing, or the announcement masked broader negative sentiment about the company.

The news headline on 2026-07-16 discloses a marketing partnership between Planet Green's subsidiary Shanghai Shuning Advertising and iFLYTEK, framed as "strategic" and involving an "AI industry leader." However, the stock plunged nearly 50% the same day the news broke. This inverse relationship between announcement and price action is striking. The headline provided contains only the opening sentence and does not detail the financial terms, exclusivity, duration, or expected revenue impact of the agreement, making it impossible to assess whether the market found the deal underwhelming or whether it flagged execution risk. Alternatively, this may indicate the announcement was a pretext or insufficient to offset pre-existing negative catalysts such as missed guidance, dilution concerns, operational challenges at the holding company, or deteriorating fundamentals in Planet Green's core business segments. Without full earnings context or prior price momentum, distinguishing between deal disappointment and company-wide deterioration is not possible from the provided snippet.

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$10.17−$6.23

-38.0%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours to explain STFS's 37.98% collapse on July 16, 2026, making the specific catalyst unclear from available public sources.

Star Fashion Culture Holdings Limited experienced a severe single-day selloff ranking fourth among NASDAQ losers, yet no relevant earnings announcements, guidance changes, regulatory actions, or corporate events appear in the recent news feed. This disconnect suggests either that news has not yet been indexed in the RSS feed, a catalyst emerged from non-traditional sources, or market movement was driven by technical factors, short liquidation, or sector-wide pressure not captured in headline data. Fashion retail and apparel stocks are cyclically sensitive and vulnerable to consumer spending concerns, supply chain disruptions, and China-related regulatory or geopolitical headwinds. Without substantive reporting, the 38% decline cannot be confidently attributed to any specific event. Investors should check SEC filings, company press releases, and trading halts directly to identify the actual cause.

ALP

Alpha Compute CorpFinancial Services

$0.20−$0.12

-36.1%

NASDAQ · Mkt cap $4.1 M

Alpha Compute shares plummeted 36% on July 16 following the release of its SEC Form 20-F filing after market close on July 15, suggesting negative earnings or financial results triggered the selloff.

The company announced on July 15 that its SEC Form 20-F would be published after market close that same day, with an investor webinar rescheduled for July 16 at 9:00 a.m. ET. The 36% single-day drop occurring on July 16 aligns with investors digesting the 20-F filing contents overnight. Form 20-F is the annual report for foreign private issuers and typically contains full-year financial results, which likely disappointed market expectations. The timing of the rescheduled webinar for the morning of the stock's worst day suggests management may have anticipated negative reaction. However, the provided headline does not explicitly disclose the filing's specific contents, earnings figures, or guidance changes. The magnitude of the decline indicates material negative news within the filing itself rather than procedural delays alone.

ARI

Apollo Commercial Real Estate Finance, Inc.Real Estate

$7.02−$3.52

-33.4%

NYSE · Mkt cap $876 M

No news headlines were found in the last 48 hours, so the 33% single-day drop in ARI cannot be directly attributed to a specific announced event; the decline likely reflects either a market-wide shock, sector rotation out of commercial real estate finance, or a delayed reaction to an earlier anno…

Apollo Commercial Real Estate Finance is a mortgage REIT that finances commercial properties, a sector sensitive to interest rates, credit conditions, and real estate valuations. A 33% single-day collapse without concurrent news suggests either a significant market event not yet captured in headlines (broader REIT sell-off, credit event, or earnings miss announced through a channel other than Yahoo Finance RSS), a technical breakdown or forced selling, or reaction to developments that occurred before the 48-hour window. REITs can be volatile on refinancing risk, default announcements, or dividend cut speculation. Without news confirmation, the exact catalyst cannot be identified, though commercial real estate finance stocks have faced structural headwinds from higher rates and rising office vacancy in recent years.

CNEY

CN Energy Group. Inc.Basic Materials

$0.67−$0.33

-33.1%

NASDAQ · Mkt cap $5.0 M

CNEY fell 33% with no news headlines in the last 48 hours, suggesting the catalyst was either an untracked announcement, technical selling, or market-wide pressure unrelated to company-specific events.

No recent news headlines were found in the last 48 hours to explain CNEY's sharp 33% decline, which ranks it among the day's seven biggest losers. This absence of identifiable news makes the root cause unclear. The most likely explanations fall into a few categories: first, a material company announcement (earnings miss, guidance cut, insider selling, debt concerns, or regulatory action) may have occurred but not yet surfaced in Yahoo Finance's RSS feed, creating a lag between the event and press pickup. Second, CNEY trades at $0.67 on NASDAQ, which typically indicates a micro-cap or penny stock subject to high volatility, thin liquidity, and sentiment-driven swings that can occur without fundamental news. Third, the move could reflect broad market technical selling or sector-specific pressure. Without access to real-time filings, press releases, or trading halts, attributing the decline to a specific catalyst is speculative.

VCIG

VCI Global LimitedIndustrials

$1.08−$0.51

-32.1%

NASDAQ · Mkt cap $2.4 M

VCI Global reported a fiscal 2025 net loss driven by restructuring costs and higher operating expenses despite technology and fintech business growth, triggering a 32% sell-off as investors reacted negatively to the loss and ongoing transition challenges.

The two headlines from July 15 both reference VCI Global's FY2025 earnings report, which disclosed a net loss amid a "transformation year" marked by restructuring costs, the spin-off of its consulting business (VCCG), and strategic shifts toward AI and next-generation technologies. While the second headline frames this as "positioning for long-term growth," the first headline explicitly states that restructuring costs and higher operating expenses offset business growth—a bearish framing that likely resonated with the market. The magnitude of the decline (32%) suggests investors either viewed the loss as unexpectedly severe, were disappointed by near-term earnings impact, or lacked confidence in management's ability to execute the turnaround. The spin-off itself may also have created uncertainty around future profitability or investor positioning. Without access to the full earnings release or guidance commentary, we cannot determine whether the loss beat or missed expectations, or what forward guidance was provided.

JAGX

Jaguar Health, Inc.Healthcare

$1.34−$0.62

-31.5%

NASDAQ · Mkt cap $4.5 M

No news headlines are available in the last 48 hours to explain JAGX's 31.54% drop, making the specific catalyst unknown without access to additional reporting or company announcements.

Jaguar Health is a small-cap biopharmaceutical company, and the absence of recent headlines despite a major single-day decline suggests the catalyst may not yet be widely covered by major financial news outlets, or it may have emerged through channels not captured in this RSS feed. Biotech stocks of this scale commonly experience sharp moves due to clinical trial results, FDA decisions, financing announcements, insider transactions, or analyst downgrades. Without confirmed news, the drop could also reflect broader market sentiment, short covering reversals, or reaction to delayed news from yesterday that hasn't yet propagated through the feed. The rank as the ninth biggest loser suggests meaningful selling pressure, but identifying its specific cause requires additional sources beyond the provided data.

GORO

Gold Resource CorporationBasic Materials

$0.93−$0.40

-30.2%

AMEX · Mkt cap $208 M

Gold Resource Corporation announced a merger with Goldgroup Mining on July 15, with the combined company's expected ticker symbol revealed. The 30% single-day drop likely reflects shareholder concern about dilution, deal terms, or the absence of specific accretion/EPS guidance in the announcement.

The headline confirms a merger announcement between GORO and Goldgroup Mining on July 15, immediately preceding the July 16 30% drop. Merger announcements in junior mining stocks commonly trigger sharp selloffs when the market perceives unfavorable terms, excessive dilution to existing shareholders, or inadequate valuation premium. The provided excerpt does not include specific details on share exchange ratio, deal closing timeline, financing terms, or management retention, which are typically critical to investor evaluation. Without visibility into whether the deal appears accretive or dilutive to GORO shareholders, or how the market is pricing synergies versus integration risk, we cannot definitively separate shareholder disappointment in the deal structure from general merger uncertainty. The magnitude of the drop (30%) suggests material concern beyond routine announcement volatility.

BBUL

GraniteShares 2x Long BB Daily ETF

$15.49−$6.28

-28.8%

NASDAQ

No news headlines found in the last 48 hours; the 28.84% drop in BBUL is most likely attributable to a sharp decline in the underlying BlackBerry stock, amplified by this leveraged 2x long daily ETF structure.

BBUL is a leveraged ETF designed to deliver twice the daily return of BlackBerry (BB). Because it uses daily rebalancing to maintain its 2x leverage, any significant single-day drop in BB would be mechanically amplified in BBUL. A roughly 14% decline in BlackBerry stock would translate to approximately the observed 28% loss in this instrument. Without recent news headlines, we cannot pinpoint the specific catalyst for BB's decline—it could stem from broader tech weakness, company-specific developments not yet reflected in the news feed, analyst downgrades, insider selling, or shifts in investor sentiment around legacy smartphone patents or licensing revenues. The absence of news does not rule out real catalyst events; it may simply reflect lags in headline indexing or breaking developments not yet widely reported.

VIVS

VivoSim Labs, Inc.Healthcare

$0.61−$0.24

-28.1%

NASDAQ · Mkt cap $1.1 M

VivoSim's 28% drop on July 16 appears driven by the announcement of a $4 million at-the-market private placement, which typically signals dilution and investor concern despite the positive $5 million Eli Lilly milestone announced the day prior.

On July 15, VivoSim announced a $5 million milestone payment from Eli Lilly and provided bullish FY2027 revenue guidance of 500%+ growth, which should have been positive for the stock. However, the very next day on July 16, the company announced a $4 million private placement priced at-the-market under Nasdaq rules from a single healthcare institutional investor. This type of announcement typically triggers sell-offs in small-cap biotech and medtech stocks because it signals equity dilution to existing shareholders and may indicate management believes the current stock price fairly values the company or that near-term capital needs are pressing. The timing—announcing the placement immediately after the Eli Lilly news—suggests either operational urgency or investor caution despite the positive milestone. The 28% single-day decline is consistent with dilutive equity offerings in this sector, particularly when the company's market cap appears modest relative to the offering size.

NBIL

GraniteShares 2x Long NBIS Daily ETF

$19.83−$7.71

-28.0%

NASDAQ

No news headlines were found in the last 48 hours, but NBIL is a 2x leveraged ETF tracking NBIS, so a sharp 28% drop likely reflects a ~14% decline in the underlying index, amplified by the daily rebalancing structure of leveraged funds.

The absence of recent news headlines means we cannot point to a specific corporate or market event announced in the past two days. However, NBIL's structure provides a concrete explanation for the magnitude of the move. As a 2x daily leveraged ETF, NBIL is designed to deliver twice the daily return of its underlying index (NBIS). A 28% single-day drop in NBIL implies approximately a 14% decline in NBIS itself. Leveraged ETFs are particularly sensitive to volatility and can experience losses beyond their stated leverage ratio if the underlying asset moves sharply and then reverses; they are not buy-and-hold instruments. The decline most likely stems from a sharp move in the underlying NBIS index on July 16, 2026, driven by broader market conditions, sector rotation, or index-specific factors. Without headline data, we cannot identify which specific event triggered the underlying move.

SGRP

SPAR Group, Inc.Industrials

$0.60−$0.23

-27.9%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours for SGRP, making the 27.90% decline difficult to attribute to a specific public announcement. The drop likely stems from technical selling, delayed news, or market sentiment unrelated to recent reportable events.

The complete absence of recent news headlines for SGRP over the past 48 hours means no earnings release, guidance revision, contract announcement, or other material event can be directly connected to today's sharp decline. For a micro-cap stock trading at $0.60, price moves of this magnitude typically reflect one of several categories: technical or algorithmic selling pressure, delayed disclosure of company developments, short covering or manipulation, broader market stress in the penny-stock or services sector, or undisclosed material information not yet published through major news channels. SPAR Group operates in facility services and merchandising, sectors that can be sensitive to economic cycles, labor cost pressures, and client concentration risk. Without headline evidence, we cannot distinguish between these possibilities.

NBIG

Leverage Shares 2x Long NBIS Daily ETF

$13.72−$5.25

-27.7%

NASDAQ

No news headlines were found in the last 48 hours. The -27.68% drop in this 2x leveraged ETF likely reflects a sharp decline in its underlying index (NBIS), which would be amplified roughly twofold by the leverage structure.

No recent news was provided to directly explain this move. However, NBIG is a 2x long leveraged daily ETF tracking the Neuberger Berman International Equity ETF (NBIS). A nearly 28% single-day loss suggests the underlying index dropped approximately 13-14%, which is an extreme move. This kind of volatility in a leveraged ETF typically stems from either a major market-wide shock (geopolitical event, central bank action, earnings-driven sector rotation, or derivative unwinding) or a significant move in the specific international equity space that NBIS covers. Without news, we cannot identify which, but the magnitude points to a systemic market event rather than company-specific news affecting the fund's holdings directly.

BEG

Leverage Shares 2x Long BE Daily ETF

$36.85−$13.42

-26.7%

NASDAQ

No news headlines were found in the last 48 hours, but BEG is a 2x leveraged ETF, so a sharp daily decline likely reflects a significant drop in its underlying asset (Boralex Inc.) rather than a discrete news event affecting the fund itself.

The absence of news in the headline feed does not mean no catalyst exists; it may simply mean the RSS feed is incomplete or the market moved on overnight volatility or sector trends. BEG is a daily reset leveraged product, meaning it amplifies the daily returns of its underlying index or stock. A -26.69% decline in a 2x long ETF is consistent with roughly a -13% move in the underlying (or steeper if the underlying opened down and continued lower through the day, given compounding and intraday rebalancing). The most likely causes for such a sharp move in the underlying would be a material announcement (earnings miss, guidance cut, regulatory action, or strategic reversal) concerning Boralex, or a broad energy/renewable sector selloff. Without specific news, we cannot pinpoint the catalyst, only confirm that the leveraged structure itself amplifies whatever moved the underlying asset.

GNPX

Genprex, Inc.Healthcare

$8.00−$2.80

-25.9%

NASDAQ · Mkt cap $2.0 M

No news headlines were reported in the last 48 hours, so the 25.92% drop cannot be attributed to a specific disclosed event; the decline likely reflects either a delayed market reaction to an earlier announcement, sector weakness, or a market-moving development not yet captured in financial news …

The absence of any recent headlines makes it impossible to pinpoint a concrete catalyst for Genprex's sharp decline. Genprex is a clinical-stage biotechnology company focused on gene therapy, a sector sensitive to clinical trial outcomes, regulatory decisions, and financing announcements. A 26% single-day drop in a biotech stock typically signals either negative clinical data, an adverse regulatory ruling, a capital raise at unfavorable terms, or a significant insider action. Without news in the last 48 hours, the move could be a delayed market reaction to an announcement from earlier in the week, a rumor circulating in biotech investor forums, short covering or liquidation, or an announcement issued after market close or on a news service not captured here. The lack of visibility into the trigger is a real limitation of the available evidence.

FGL

Founder Group LimitedIndustrials

$0.94−$0.32

-25.4%

NASDAQ · Mkt cap $475 K

No news headlines were found in the last 48 hours explaining FGL's steep 25.4% single-day drop, so the cause remains unclear from publicly available sources.

The absence of any recent news headlines in the provided feed makes it impossible to attribute this sharp decline to a specific company announcement, earnings report, regulatory action, or market event. A 25% single-day move in a micro-cap stock like FGL (trading at $0.94) could stem from several categories of catalysts: a delayed press release or filing not yet picked up by RSS feeds, insider trading activity or Form 4 disclosures, technical selling pressure or liquidity constraints common in penny stocks, sector-wide weakness affecting similar companies, analyst downgrades, or social media-driven sentiment shifts. Without corroborating news or structural insight into FGL's current business situation, capital structure, or trading patterns, any explanation remains speculative. The timing gap between the price action and news availability also suggests the catalyst may have occurred but not yet propagated through standard financial media channels.

SST

System1, Inc.Industrials

$1.91−$0.63

-24.8%

NYSE · Mkt cap $22 M

SST fell 24.8% on July 16 with no news headlines identified in the last 48 hours, making the specific cause unclear, though the move suggests either a delayed negative announcement, earnings miss, or broad sector selloff.

No recent news headlines were found in the Yahoo Finance RSS feed for the last 48 hours, so the catalyst for this steep single-day decline cannot be directly identified from the information provided. System1 is a performance marketing and digital advertising company, sectors that can be sensitive to changes in ad spending trends, regulatory shifts in data privacy, or company-specific operational updates. Without access to earnings releases, guidance changes, insider transactions, or other company announcements, the most likely explanations fall into three categories: a delayed earnings or guidance announcement that moved markets overnight or early morning before news aggregation, adverse industry or macroeconomic news affecting digital advertising broadly, or a technical or volume-driven sell-off. The 24.8% single-day drop is severe enough to suggest a material negative development rather than ordinary volatility, but the absence of contemporaneous headlines limits confidence in any specific conclusion.

VMAR

Vision Marine Technologies Inc.Consumer Cyclical

$1.00−$0.31

-24.0%

NASDAQ · Mkt cap $4.6 M

Vision Marine Technologies fell 24% on July 16 with no headlines in the last 48 hours, making the specific cause unclear without access to real-time news or intraday events.

The absence of any news headlines in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to a specific catalyst such as earnings, product delays, regulatory action, or financing news. A 24% single-day drop is severe and suggests a material negative event. For a small-cap marine technology company like Vision Marine, typical catalysts for such moves include disappointing product announcements or pilot programs, cash burn concerns driving dilution fears, contract cancellations or customer losses, insider selling disclosures, or short-seller reports. Alternatively, the drop could reflect a delayed market reaction to news that broke before the RSS capture window, or technical selling into low liquidity. Without direct access to company filings, SEC reports, or real-time market data from July 16, the specific trigger remains unconfirmed.

LABT

Lakewood-Amedex Biotherapeutics Inc. Common StockHealthcare

$1.85−$0.58

-23.9%

NASDAQ · Mkt cap $3.8 M

LABT fell 23.87% on July 16 despite announcing preclinical safety data for its Nu-3 Gel Phase 2a trial on July 15, suggesting the market either viewed the data as insufficient or reacted to factors unrelated to the headline.

The company released preclinical safety data on July 15 intended to support clinical dose selection for an upcoming Phase 2a trial of Nu-3 Gel, a novel antimicrobial candidate. This is ordinarily positive news for a clinical-stage biotech. However, the stock dropped sharply the next trading day, which indicates either that investors found the disclosed data disappointing relative to expectations, or that the move was driven by something other than this announcement. Clinical-stage biotech stocks are highly sensitive to trial progress, competitive threats, funding concerns, and broader sector sentiment. Without access to the full text of the announcement or analyst commentary, it is unclear whether the data fell short, whether there were unfavorable details in the release, or whether an unrelated catalyst triggered the decline. The magnitude of the loss ranks it among the day's worst performers, suggesting a material negative catalyst rather than routine volatility.

KIDZ

KIDZ AI Inc.Consumer Defensive

$0.45−$0.14

-23.6%

RKLX

Daily Target 2X Long RKLB ETF

$18.44−$5.64

-23.4%

NASDAQ

No news headlines are available to explain the 23.42% decline, but RKLX is a 2X leveraged long ETF on Rocket Lab (RKLB), so the drop likely reflects a significant decline in the underlying stock amplified by the fund's leverage structure.

No news was found in the last 48 hours on Yahoo Finance RSS, so we cannot point to a specific catalyst such as earnings, guidance, contract loss, or other discrete event. However, RKLX is a daily target 2X leveraged long ETF tracking Rocket Lab (RKLB), meaning it is designed to deliver twice the daily return of its underlying stock. A 23.42% drop in RKLX would be consistent with approximately an 11-12% decline in RKLB itself, amplified by the 2X leverage. The absence of news headlines does not mean there was no catalyst—it may simply indicate that market-moving information on RKLB either did not appear in the RSS feed captured, or that the move was driven by technical selling, sector rotation, or market-wide volatility rather than company-specific news. Leveraged ETFs also suffer from decay in sideways or volatile markets, though a single-day 23% drop suggests underlying asset weakness rather than decay alone.

MODD

Modular Medical, Inc.Healthcare

$3.24−$0.95

-22.7%

NASDAQ · Mkt cap $13 M

MODD fell 22.67% despite announcing two positive strategic developments with IMO Health and favorable payor research on its Pivot pump, suggesting the sell-off was driven by factors unrelated to these announced initiatives.

The two headlines released in the last 48 hours are operationally positive—a pilot program launch with IMO Health to integrate insulin pump patient data into EHRs, and independent research showing strong payor receptivity to the Pivot tubeless patch pump design. Neither announcement appears negative or represents a material setback. The magnitude of the decline (22.67%, ranking it 24 worst performer) far outweighs typical single-day reactions to pilot program announcements or favorable preliminary studies. This disconnect suggests the sell-off may be driven by broader market conditions affecting small-cap medtech stocks, a delayed reaction to unreported news, or technical/momentum factors unrelated to the announced initiatives. Without earnings data, FDA decisions, guidance changes, or market context, the specific catalyst remains unclear.

RBNE

Robin Energy Ltd.Energy

$4.10−$1.17

-22.2%

PUR

Defiance Daily Target 2X Long PURR ETF

$13.30−$3.76

-22.1%

NASDAQ

No news was published in the last 48 hours, but PUR is a 2X leveraged long ETF tracking the Puretana stock, so a sharp underlying decline would be amplified roughly twofold in this fund.

Zero headlines appeared in the 48-hour window before this 22% drop, so the direct cause cannot be attributed to a named company announcement, earnings surprise, or regulatory action. However, PUR's structure as a daily target 2X long leveraged ETF is critical context. This fund amplifies daily moves in its underlying asset by approximately two times, meaning a roughly 11% drop in the underlying Puretana security would produce approximately a 22% fund decline. The lack of news does not explain the underlying move itself, but it does explain why this ETF moved so sharply relative to a non-leveraged holder. The true catalyst lies in the underlying stock's price action, which could reflect technical selling, sector weakness, delayed earnings disappointment, insider action, or other factors not captured in this news feed.

CIFG

Leverage Shares 2X Long CIFR Daily ETF

$6.57−$1.85

-21.9%

NASDAQ

No news headlines were published in the last 48 hours, but CIFG is a 2X leveraged long ETF tracking CIFR, so a sharp underlying decline would be amplified roughly twofold in this derivative instrument.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours means we cannot point to a specific company event, earnings release, regulatory action, or market catalyst for CIFG's 21.93% drop. However, CIFG is structurally a leveraged ETF—it aims to deliver twice the daily return of its underlying index or security (CIFR). This means that if CIFR declined roughly 11%, CIFG would decline roughly 22% as a mechanical consequence of the leverage. The real driver of the move is therefore whatever caused CIFR itself to fall, which could include broad sector weakness, a correction in the underlying asset class, rebalancing losses inherent to daily reset mechanisms in leveraged products, or any catalyst specific to CIFR's holdings. Without news on CIFR or broader market context, we cannot identify which of these categories was responsible.

BTDL

GraniteShares 2x Long BTDR Daily ETF

$20.88−$5.85

-21.9%

NASDAQ

No news headlines were published in the last 48 hours, but the -21.88% drop in this 2x leveraged Bitcoin ETF likely reflects a sharp decline in Bitcoin or broader crypto weakness that day, amplified by the fund's daily reset mechanism.

BTDL is a 2x leveraged daily reset ETF tracking Bitcoin futures. Without headlines from the past 48 hours, the move cannot be attributed to company-specific news or announcements. However, the structure of this security means it is highly sensitive to Bitcoin price movements, and a leveraged product will amplify daily losses significantly. A 10-11% decline in Bitcoin would mechanically produce approximately a 20-22% loss in a 2x daily-reset product, which aligns closely with the observed -21.88% move. The absence of news headlines suggests the catalyst was either a broad cryptocurrency market downturn, technical selling, or a macroeconomic event affecting risk assets. Structural leverage, not fundamental news, is the most likely explanation for the magnitude of the loss.

JLHL

Julong Holding LimitedIndustrials

$8.44−$2.31

-21.5%

NASDAQ · Mkt cap $152 M

JLHL dropped 21.49% on July 16 with no news headlines in the last 48 hours, making the specific catalyst unclear and likely driven by technical selling, market sentiment, or undisclosed corporate developments.

No recent news headlines are available to explain the sharp 21.49% decline in JLHL. Without identified catalysts such as earnings misses, guidance cuts, regulatory actions, or material announcements, the move must be attributed to other factors. For a NASDAQ-listed company experiencing this magnitude of loss on a single day, plausible causes include technical breakdown or profit-taking after a run-up, sector-wide selloff affecting similar securities, an unannounced or delayed earnings result, executive departures, litigation or regulatory concerns not yet reflected in public news feeds, or short-seller activity. Additionally, lower-volume or smaller-cap stocks can experience outsized moves on algorithmic selling or index rebalancing. Without access to intraday trading data, halt reasons, or internal corporate developments, the precise trigger remains speculative.

SNTI

Senti Biosciences, Inc.Healthcare

$0.46−$0.12

-21.2%

NASDAQ · Mkt cap $14 M

Senti Biosciences announced a strategic transaction including a spin-off of its SENTI-202 program, which likely spooked investors due to dilution concerns or uncertainty about the restructuring's value creation despite management's stated aim to unlock value.

On July 15, Senti announced a spin-off transaction designed to separate its pipeline including SENTI-202 into a dedicated entity focused on its Regulator Dial technology platform. The company framed this as a value-unlock move, but biotech investors often react negatively to spinoffs in the near term due to several factors: dilution of existing shareholder stakes, near-term execution risk, potential loss of scale or cost synergies, and uncertainty about standalone viability. The announcement's reference to contingent value rights suggests a complex capital structure outcome that may have raised concerns about the transaction's fairness or the receiving company's financial stability. Without clarity on specific terms, valuation bridge, or investor enthusiasm, markets defaulted to skepticism about whether a smaller, standalone gene-therapy company can compete effectively or reach profitability.

OMH

Ohmyhome LimitedReal Estate

$0.28−$0.07

-21.1%

NASDAQ · Mkt cap $7.7 M

Ohmyhome announced receipt of a Nasdaq notification on July 13 regarding minimum bid price deficiency, which likely triggered the 21% single-day drop as the market priced in delisting risk.

The headline confirms Ohmyhome received formal notification from Nasdaq regarding a minimum bid price deficiency. This is a concrete compliance warning that precedes potential delisting if the stock fails to meet Nasdaq's minimum bid price requirement within a specified cure period, typically 180 calendar days. Such notifications are material events that directly threaten a company's exchange listing status and are typically met with sharp sell-offs as investors flee the stock due to regulatory risk and reduced liquidity. The stock's current price of $0.28 suggests it has been trading well below Nasdaq's $1.00 minimum bid price threshold for some time, and this formal notification makes the delisting threat explicit rather than theoretical.

CIIT

Tianci International, Inc.Industrials

$0.32−$0.09

-21.0%

NASDAQ · Mkt cap $3.4 M

Tianci International announced a 1-for-10 reverse stock split effective July 20, which typically signals financial distress and dilution concerns, likely driving the 21% single-day decline as investors sold ahead of the adjustment.

The company announced a reverse stock split on July 16, with trading on a split-adjusted basis beginning July 20. Reverse splits are generally perceived as negative signals by the market because they are typically executed by companies facing delisting risks, severe stock price erosion, or balance sheet challenges. While the headline does not provide explicit detail on the company's financial condition or reason for the split, the timing of the stock's sharp decline coinciding with the announcement suggests investors interpreted this as a red flag. The mechanical adjustment itself—reducing share count tenfold—does not change intrinsic value but often precedes further deterioration. Without additional context on Tianci's operational performance, debt levels, or NASDAQ compliance status, the move appears driven by negative sentiment around what the reverse split implies about the company's health rather than any positive catalysts.

CRMU

Leverage Shares 2x Long CRML Daily ETF

$2.45−$0.62

-20.3%

NASDAQ

No news headlines were found in the last 48 hours, but CRMU is a 2x leveraged ETF tracking CRML, so a roughly 10% decline in the underlying stock would mechanically produce this approximately 20% drop in the fund.

The absence of news in the search results does not mean no catalyst occurred; rather, the move is consistent with what a 2x daily leveraged long ETF would experience if its underlying asset (CRML, likely Cereus Minerals or a similar ticker) declined roughly 10% on the day. Leveraged ETFs amplify both gains and losses of their tracking index by their stated multiple, so a -10% move in CRML would translate to approximately -20% for a 2x long product. The true cause of the move therefore resides in CRML's own price action. Without headlines about CRML itself, the driver could be sector weakness, a company-specific catalyst in CRML not yet syndicated to Yahoo Finance, or broader market conditions on July 16, 2026.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$1.96−$0.50

-20.3%

NASDAQ · Mkt cap $88 M

No news headlines were available in the last 48 hours to explain the sharp 20.33% decline in MWC, so the cause remains unclear; the drop may reflect delayed earnings, analyst downgrades, broader sector weakness, or undisclosed corporate developments.

MWC experienced a significant single-day loss of over 20% while ranking among the day's top 34 losers, yet no news headlines were captured in the Yahoo Finance RSS feed for the preceding 48 hours. This absence of publicly available news does not rule out material corporate announcements—earnings reports, guidance changes, insider transactions, or sector-specific adverse developments could have occurred outside the RSS window or on a venue not covered by the feed. Alternatively, the decline may reflect technical selling pressure, accumulation of negative sentiment from prior weeks, or sector rotation away from technology or semiconductor stocks. For a smaller-cap or lower-liquidity stock like an ADR, single-day volatility can also be amplified by thin trading or hedge fund redemptions unrelated to company-specific news.

ELVA

Electrovaya Inc.Industrials

$9.54−$2.22

-18.9%

NASDAQ · Mkt cap $381 M

Electrovaya surged 40-49% on July 15 following a major Amazon battery supply deal, but profit-taking and warrant dilution concerns likely triggered the 18.88% decline on July 16 as investors reassessed valuation after the initial euphoria faded.

The news sequence shows Electrovaya announced a commercial agreement and warrant transaction with Amazon on July 15, sparking a 40-49% single-day rally—described as the best day in over 13 years. The deal grants Amazon options to purchase over 20% of Electrovaya's shares contingent on future product purchases for material handling and potential robotics applications. While fundamentally positive, warrant issuance creates dilution risk and the stock's explosive move created a natural reversion environment on July 16. The headline from July 16 midday ("Has The Bull Case Changed?") and analyst commentary noting the move "may not translate into further price increase" suggest investors began questioning whether the rally had priced in too much upside too quickly. A 49% one-day jump followed by an 18.88% pullback the next day is textbook post-announcement volatility rather than news-driven deterioration, though warrant dilution and execution risk on Amazon's conditional purchases may have contributed to profit-taking.

ENLV

Enlivex Therapeutics Ltd.Healthcare

$4.75−$1.09

-18.7%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 18.66% drop cannot be attributed to a specific announced event; the decline likely reflects either delayed reaction to earlier news, technical selling, or market sentiment shift in the biotech sector.

Enlivex Therapeutics is a clinical-stage biopharmaceutical company focused on immune-modulation therapies, a sector known for high volatility driven by clinical trial outcomes, regulatory decisions, and investor risk appetite shifts. The absence of recent news headlines suggests the move was not triggered by a company-specific announcement released in the last two days. For biotech stocks of this type, significant single-day declines often stem from clinical trial setbacks, regulatory feedback, capital raise announcements at unfavorable terms, analyst downgrades, or broader sector rotation away from early-stage therapeutics. Without a specific headline, we cannot definitively link this drop to any particular catalyst, though it may represent a delayed market reaction to news released before the 48-hour window, changes in sentiment toward the company's pipeline, or liquidity-driven selling in a lower-volume equity.

WKSP

Worksport Ltd.Consumer Cyclical

$0.66−$0.15

-18.6%

NASDAQ · Mkt cap $9.8 M

No news headlines were found in the last 48 hours, so the 18.64% drop cannot be attributed to a specific announced catalyst. The decline likely reflects broad selling pressure, technical weakness, or undisclosed market rumors affecting this micro-cap stock.

Worksport Ltd. is a small-capitalization company trading at $0.66 per share, and the absence of recent news coverage makes it difficult to identify a specific triggering event. Stocks in this price range and market-cap category are typically subject to high volatility and can be sensitive to sector rotation, liquidity events, or rumors that may not be immediately picked up by mainstream financial news feeds. Possible categories of cause include technical breakdown and stop-loss cascades, sector-wide headwinds affecting automotive or specialty equipment suppliers, insider transactions or Form 4 filings not yet surfaced in headlines, or unconfirmed speculation on social media or message boards. Without corroborating news or filings, these remain hypotheses rather than confirmed explanations.

NTRP

NextTrip, Inc.Consumer Cyclical

$1.66−$0.38

-18.6%

NASDAQ · Mkt cap $22 M

NextTrip reported Q1 earnings late on July 15, beating revenue estimates by nearly 10% with 900%+ year-over-year growth, yet the stock fell 18.6% the next day, suggesting investors were disappointed by profitability despite the strong topline beat.

NextTrip released first-quarter fiscal 2027 results showing revenue of $1.45 million, representing massive growth and a +9.98% beat versus estimates. The company is transitioning toward higher-margin travel, media, and creator commerce initiatives. However, the headlines explicitly state the company "Reports Q1 Loss," indicating the firm remains unprofitable despite revenue growth. In many growth-stage companies, especially those in transition phases, a topline beat coupled with continued losses or narrowing margins can trigger sharp sell-offs if investors perceive profitability is taking longer to materialize than expected. The 18.6% one-day drop suggests the market's focus was on the earnings miss (the loss itself) rather than the revenue upside, or that guidance and forward commentary disappointed relative to the growth narrative.

HIMZ

Daily Target 2X Long HIMS ETF

$44.71−$10.19

-18.6%

NASDAQ

No news headlines were available in the last 48 hours, but HIMZ is a 2X leveraged long ETF tracking Telemedicine & Health Services stocks, so it likely declined due to weakness in the underlying sector or broader market selloff that was magnified by its leverage structure.

The absence of any news in the last 48 hours means we cannot point to a company-specific catalyst for Teladoc Health Inc (the primary holding in many telemedicine ETFs) or HIMZ itself. However, HIMZ is a daily reset 2X leveraged product, which means it amplifies both gains and losses of its underlying index by roughly double on a daily basis. An 18.56% drop in HIMZ would suggest approximately a 9-10% decline in the underlying telemedicine index or its key constituents. This type of move in a leveraged health tech ETF typically reflects sector-wide pressure—possibly from broader healthcare selloffs, interest rate concerns affecting high-growth healthcare stocks, or negative sentiment toward digital health companies. Without headline evidence, the decline appears driven by market dynamics rather than isolated HIMZ news.

GLGG

Leverage Shares 2x Long GLXY Daily ETFFinancial Services

$4.97−$1.12

-18.4%

GLWG

Leverage Shares 2X Long GLW Daily ETF

$16.26−$3.63

-18.3%

NASDAQ

No news headlines were available in the last 48 hours, but GLWG is a 2X leveraged long ETF on Corning (GLW), so an 18% drop likely reflects a significant decline in the underlying stock, amplified by the fund's leverage structure.

No recent news was found to explain the move directly. However, GLWG is a leveraged ETF product designed to track twice the daily return of Corning Inc. (GLW). This means if GLW fell roughly 9% on this date, GLWG would be expected to fall approximately 18%, which matches the observed decline. The cause of the underlying decline in Corning could stem from several typical drivers in the materials or technology sectors: earnings disappointment, downward guidance revision, weakness in optical communications or consumer electronics demand, broader semiconductor or supply-chain concerns, or general market selloff. Without access to Corning-specific news or market data for the underlying stock, we cannot identify the specific catalyst, only that the leveraged ETF is functioning mechanically as designed in response to its underlying moving sharply lower.

IRE

Defiance Daily Target 2X Long IREN ETF

$9.02−$2.00

-18.1%

AMEX

No news headlines were published in the last 48 hours, but IRE is a 2X leveraged long ETF tracking IREN, so a sharp decline in the underlying stock would be amplified roughly twofold in this product's price action.

No recent news was available to explain today's 18.15% drop. However, IRE's structure as a daily target 2X leveraged long ETF means its price movements are mechanically amplified relative to its underlying asset. If IREN (the underlying stock) fell roughly 9-10% today, that would naturally produce an 18-20% decline in this leveraged product, even without any company-specific catalyst. The most likely explanation is therefore a significant move in IREN itself, possibly driven by broader market conditions, sector weakness, technical selling, or an unreported development in the underlying company. Without visibility into IREN's own news or price action, the root cause remains unknown, but the magnitude of the IRE move is consistent with normal leveraged ETF behavior during a down day in its underlying.

HPAI

Helport AI LimitedTechnology

$0.46−$0.10

-17.9%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 17.95% decline cannot be directly attributed to a specific announcement. The drop likely reflects sector headwinds, profit-taking, or technical selling in a low-priced stock.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours means this move cannot be tied to a company-specific catalyst such as earnings, guidance, partnerships, or regulatory developments. For a microcap stock trading at $0.46, declines of this magnitude are common and can result from several typical causes: sector-wide pullbacks affecting AI-related names, momentum reversal or profit-taking after a prior run, low liquidity amplifying selling pressure, or technical chart breaks. Small-cap and penny stocks are particularly prone to daily swings driven by retail trading activity, short covering, or delayed news propagation. Without headline confirmation, the specific trigger remains unknown.

MVLL

GraniteShares 2x Long MRVL Daily ETF

$21.46−$4.66

-17.8%

NASDAQ

No news headlines were found in the last 48 hours, but MVLL is a 2x leveraged ETF on Marvell Technology, so a sharp one-day drop almost certainly reflects a significant decline in the underlying MRVL stock.

MVLL is a daily reset leveraged ETF that aims to deliver twice the daily return of Marvell Technology (MRVL). A -17.84% single-day loss in MVLL strongly implies MRVL fell roughly 8-9% on the same day. Without news headlines provided, the specific catalyst for Marvell's decline is not directly visible here. However, this kind of stock typically responds to semiconductor sector dynamics, earnings surprises, guidance changes, competitive pressures, or macro shifts affecting chip demand. The absence of headlines in the Yahoo Finance RSS feed in the last 48 hours suggests either the move occurred early in the day before full news dissemination, or the market reaction may have been driven by technical factors, sector-wide weakness, or delayed news pickup. The leveraged structure of MVLL amplifies whatever happened to MRVL, making it appear as one of the day's biggest losers even if the underlying move was moderate.

KALA

KALA BIO, Inc.Healthcare

$0.85−$0.18

-17.8%

IREG

Leverage Shares 2x Long IREN Daily ETF

$7.16−$1.54

-17.7%

NASDAQ

No news headlines were found in the last 48 hours. The 17.7% decline in this 2x leveraged ETF most likely reflects a sharp drop in its underlying stock IREN, amplified by the leverage structure.

The absence of recent news headlines means no specific corporate event (earnings, guidance, FDA action, acquisition) can be identified as the direct cause of this move. However, IREG is a 2x long leveraged daily ETF tracking IREN, which means it amplifies daily moves in the underlying security by a factor of two. A roughly 8-9% decline in IREN would produce approximately this 17.7% loss in IREG. The catalyst for the underlying move could be market-wide volatility, sector rotation, company-specific technical breakdown, delayed news absorption, or short-term trader exit, but without headlines or visibility into IREN's own price action and fundamentals, the root cause remains opaque. Leveraged ETF holders also face decay risk in volatile markets, though that typically compounds over time rather than causing acute single-day spikes.

MRVU

Direxion Daily MRVL Bull 2X ETF

$86.53−$18.60

-17.7%

NASDAQ

No news headlines were available in the last 48 hours, but MRVU is a 2X leveraged bull ETF on Marvell Technology, so a sharp drop likely reflects a significant decline in the underlying MRVL stock, amplified by the 2X leverage.

MRVU is a leveraged ETF designed to deliver twice the daily return of Marvell Technology (MRVL). With a 17.69% decline, the underlying stock likely fell approximately 8-9% on July 16 or in the preceding session. Without news headlines to identify a specific catalyst, the most probable explanations are either a major market-wide tech selloff, negative company-specific news about Marvell that simply wasn't captured in the RSS feed provided, or a significant technical breakdown in the semiconductor or chip design sector. Leveraged ETFs amplify both gains and losses, so any material weakness in MRVL gets magnified in MRVU. The absence of headlines does not rule out an earnings miss, guidance cut, analyst downgrade, or product setback affecting Marvell directly, but we cannot confirm any such event from the data supplied.

OKLL

Daily Target 2X Long OKLO ETF

$3.00−$0.64

-17.6%

NASDAQ

No news headlines were found in the last 48 hours, but OKLL is a 2X leveraged long ETF tracking OKLO, so a sharp decline likely reflects a significant drop in the underlying advanced nuclear stock or broader market weakness amplified by the fund's leverage structure.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for today's 17.58% decline. However, OKLL is a leveraged ETF designed to deliver twice the daily return of the OKLO index, which means it will amplify both gains and losses in the underlying holdings. A drop of this magnitude in a 2X leveraged product typically implies the underlying OKLO holdings fell roughly 8-9% or more, suggesting material selling pressure in advanced nuclear energy stocks. This could stem from sector rotation, broader market selloff, concerns about regulatory or funding developments in the nuclear sector, or other equity-market dynamics. Without headline confirmation, the specific trigger remains unknown, but the leverage structure itself mechanically explains why OKLL fell harder than its underlying index would have.

FTH

Faeth Therapeutics, Inc.Healthcare

$25.94−$5.53

-17.6%

NASDAQ · Mkt cap $1.0 B

No news headlines were found in the last 48 hours, so the cause of the 17.57% decline cannot be determined from reported developments. The drop likely reflects either a delayed market reaction to an untracked event, technical selling, or sector headwinds affecting biotech stocks.

The absence of any recent news from Yahoo Finance RSS in the last 48 hours makes it impossible to point to a specific catalyst for Faeth's sharp 17.57% decline. For a small-cap therapeutic company like Faeth, large single-day moves often correlate with clinical trial data, regulatory decisions, partnership announcements, or changes in management or financial guidance. The magnitude of the drop suggests a material negative event rather than routine trading. Without access to real-time news streams, social media discussions, or company filings beyond Yahoo Finance's feed, the actual trigger remains unknown. Possibilities include a delayed clinical setback reported elsewhere, broader biotech sector weakness, short covering reversals, or a company announcement made through other channels.

BGDE

Big Digital Energy, Inc.Financial Services

$5.26−$1.10

-17.3%

NASDAQ · Mkt cap $41 M

No news headlines were reported in the last 48 hours for BGDE, so the 17.3% drop cannot be attributed to a specific announced event; the cause likely involves technical selling, sector rotation, or non-public market developments.

Big Digital Energy's steep 17.3% single-day decline occurred in the absence of any reported headlines from major news sources in the prior 48 hours. This disconnect between a significant price move and public news flow is noteworthy. For a company in the energy or digital infrastructure space, typical catalysts for such drops would include earnings misses, guidance cuts, analyst downgrades, sector-wide commodity or regulatory headwinds, or loss of a major contract. The absence of headlines suggests either that the move was driven by technical factors such as a stop-loss cascade or algorithmic selling, that market sentiment shifted on non-headline information flow, or that the relevant news had not yet reached primary news aggregators. Without visibility into social media, insider transactions, or private market chatter, attribution remains speculative.